Piramal Enterprises

Piramal Enterprises raises investment in Shriram group to nearly Rs4,500 cr

05 Jun 2014

Piramal to sell entire stake in Vodafone India for Rs8,900 crore

10 Apr 2014

Ajay Piramal-led Piramal Enterprises Ltd today agreed to sell its 10.97 per cent stake in Vodafone India Ltd to parent Vodafone Group Plc, for Rs8,900 crore

Piramal Enterprises joins hands with Tata Memorial for cancer research

03 Apr 2013

Piramal arm buys market analytics firm Abacus in UK

04 Dec 2012

Piramal to buy US healthcare data firm Decision Resources for Rs3,400 crore

16 May 2012

Piramal Healthcare buys Bayer’s molecular imaging and research portfolio

16 Apr 2012

The acquisition includes Florbetaben, a drug candidate for diagnosis of Alzheimer’s disease that is in the final stages of clinical trials, with potential to generate annual revenues of $1.5 billion

Piramal Healthcare gets EU approval for its regenerative product `BST-CarGel’

11 Apr 2012

Piramal Healthcare to buy additional 5.5% in Vodafone India for Rs3,007 cr

04 Feb 2012

Piramal Healthcare acquires 5.5-% Vodafone Essar stake for $640 million

11 Aug 2011

Drug-maker Piramal Healthcare has picked up a 5.5-per cent equity stake in Vodafone Essar Ltd, the Indian unit of world's second-largest mobile operator